<?xml version="1.0" encoding="UTF-8"?><rss version="2.0" xmlns:content="http://purl.org/rss/1.0/modules/content/"><channel><title>行舟Drug | wechat-feeds</title><link>http://MzUxNTM5MDcwMA.favicon.privacyhide.com/favicon.ico</link><description>It takes nothing to join the crowd, but it takes everything to stand alone</description><managingEditor> (hellodword)</managingEditor><pubDate>Wed, 21 Apr 2021 07:22:55 +0800</pubDate><image><url>http://MzUxNTM5MDcwMA.favicon.privacyhide.com/favicon.ico</url><title>行舟Drug | wechat-feeds</title><link>http://MzUxNTM5MDcwMA.favicon.privacyhide.com/favicon.ico</link><width>64</width><height>64</height></image><item><title>创新药临床期间药学变更</title><link>https://mp.weixin.qq.com/s/Asc9BFyvt1gp1LOQhhFr8w</link><description></description><content:encoded><![CDATA[创新药临床期间药学变更]]></content:encoded><pubDate>Tue, 20 Apr 2021 20:31:37 +0800</pubDate></item><item><title>恒瑞 PD-1 鼻咽癌新适应症即将获批</title><link>https://mp.weixin.qq.com/s/AIBwfu13QZYlJJe9_bdT-g</link><description></description><content:encoded><![CDATA[恒瑞 PD-1 鼻咽癌新适应症即将获批]]></content:encoded><pubDate>Tue, 20 Apr 2021 20:31:37 +0800</pubDate></item><item><title>新一代双特异性抗体抗肿瘤疗法的研发挑战及解决策略</title><link>https://mp.weixin.qq.com/s/4co7MIFXwYyLfysyh8os7w</link><description></description><content:encoded><![CDATA[新一代双特异性抗体抗肿瘤疗法的研发挑战及解决策略]]></content:encoded><pubDate>Tue, 20 Apr 2021 20:31:37 +0800</pubDate></item><item><title>强降解试验中的质量守衡</title><link>https://mp.weixin.qq.com/s/M_3ZUtH8XoZO8z5UfjR-pQ</link><description></description><content:encoded><![CDATA[强降解试验中的质量守衡]]></content:encoded><pubDate>Tue, 20 Apr 2021 20:31:37 +0800</pubDate></item><item><title>注射剂无菌工艺验证</title><link>https://mp.weixin.qq.com/s/jmF-ALRrPhzGUyLEzekPKw</link><description></description><content:encoded><![CDATA[注射剂无菌工艺验证]]></content:encoded><pubDate>Mon, 19 Apr 2021 19:42:51 +0800</pubDate></item><item><title>异体CAR-T细胞疗法最新研究进展</title><link>https://mp.weixin.qq.com/s/CV52wpk3fkbgxbyiwC-AGg</link><description></description><content:encoded><![CDATA[异体CAR-T细胞疗法最新研究进展]]></content:encoded><pubDate>Mon, 19 Apr 2021 19:42:51 +0800</pubDate></item><item><title>【专家解读】《中华人民共和国生物安全法》</title><link>https://mp.weixin.qq.com/s/WdqGNeZkVPkLqkWvunD6bw</link><description></description><content:encoded><![CDATA[【专家解读】《中华人民共和国生物安全法》]]></content:encoded><pubDate>Mon, 19 Apr 2021 19:42:51 +0800</pubDate></item><item><title>严重副作用不同疾病的对应手册（面向患者·公众）（61）-吉兰巴雷综合征</title><link>https://mp.weixin.qq.com/s/csCN_exfi7EGzWUIWWkH-w</link><description></description><content:encoded><![CDATA[严重副作用不同疾病的对应手册（面向患者·公众）（61）-吉兰巴雷综合征]]></content:encoded><pubDate>Sun, 18 Apr 2021 20:47:17 +0800</pubDate></item><item><title>2021.V1 NCCN指南——子宫肿瘤</title><link>https://mp.weixin.qq.com/s/BNdwZnDle-cRoY8tNsa0xg</link><description></description><content:encoded><![CDATA[2021.V1 NCCN指南——子宫肿瘤]]></content:encoded><pubDate>Sun, 18 Apr 2021 20:47:17 +0800</pubDate></item><item><title>2021年一季度疫苗行业批签发数据跟踪</title><link>https://mp.weixin.qq.com/s/c8AAOvirc-40NawvUQKjBw</link><description></description><content:encoded><![CDATA[2021年一季度疫苗行业批签发数据跟踪]]></content:encoded><pubDate>Sun, 18 Apr 2021 20:47:17 +0800</pubDate></item><item><title>免疫细胞和病毒战斗全过程！</title><link>https://mp.weixin.qq.com/s/9SuBQdKij_AZ684Rb-RjfA</link><description></description><content:encoded><![CDATA[免疫细胞和病毒战斗全过程！]]></content:encoded><pubDate>Sat, 17 Apr 2021 20:05:31 +0800</pubDate></item><item><title>FDA是如何做分析方法验证</title><link>https://mp.weixin.qq.com/s/K5dUJSBw098eBqe9296G8w</link><description></description><content:encoded><![CDATA[FDA是如何做分析方法验证]]></content:encoded><pubDate>Sat, 17 Apr 2021 20:05:31 +0800</pubDate></item><item><title>FDA对美国生物类似物开发和批准的监管指南概述</title><link>https://mp.weixin.qq.com/s/Am0184SEb0S90ixgAsLOvw</link><description></description><content:encoded><![CDATA[FDA对美国生物类似物开发和批准的监管指南概述]]></content:encoded><pubDate>Sat, 17 Apr 2021 20:05:31 +0800</pubDate></item><item><title>漫画| 免疫细胞，它是如何保护我们的身体？</title><link>https://mp.weixin.qq.com/s/zGTbqjkBxUbREM4ec7_48g</link><description></description><content:encoded><![CDATA[漫画| 免疫细胞，它是如何保护我们的身体？]]></content:encoded><pubDate>Fri, 16 Apr 2021 21:19:09 +0800</pubDate></item><item><title>一图读懂｜救命药变“白菜价”，肺癌药物医保那些事儿！</title><link>https://mp.weixin.qq.com/s/4ca3JQtbFc3XThCHqWksng</link><description></description><content:encoded><![CDATA[一图读懂｜救命药变“白菜价”，肺癌药物医保那些事儿！]]></content:encoded><pubDate>Fri, 16 Apr 2021 21:19:09 +0800</pubDate></item><item><title>异体CAR-T细胞疗法最新研究进展</title><link>https://mp.weixin.qq.com/s/XZE7E7kzdSysJ8e6s59ReQ</link><description></description><content:encoded><![CDATA[异体CAR-T细胞疗法最新研究进展]]></content:encoded><pubDate>Fri, 16 Apr 2021 21:19:09 +0800</pubDate></item><item><title>CDE：登录《申请人之窗》栏目即将启用“短信验证码”安全校验功能</title><link>https://mp.weixin.qq.com/s/jHTRZ6vZnQXE2jLPVBWAfw</link><description></description><content:encoded><![CDATA[CDE：登录《申请人之窗》栏目即将启用“短信验证码”安全校验功能]]></content:encoded><pubDate>Thu, 15 Apr 2021 19:26:41 +0800</pubDate></item><item><title>【重磅】CDE发布《用于产生真实世界证据的真实世界数据指导原则（试行）》</title><link>https://mp.weixin.qq.com/s/32tyPtPzLZO2WbYV3tvtRg</link><description></description><content:encoded><![CDATA[【重磅】CDE发布《用于产生真实世界证据的真实世界数据指导原则（试行）》]]></content:encoded><pubDate>Thu, 15 Apr 2021 19:26:41 +0800</pubDate></item><item><title>干货丨FDA关于冻干工艺性能验证观点(ppt)</title><link>https://mp.weixin.qq.com/s/NwRQL7oCIP4BD0p_9qsz6w</link><description></description><content:encoded><![CDATA[干货丨FDA关于冻干工艺性能验证观点(ppt)]]></content:encoded><pubDate>Thu, 15 Apr 2021 19:26:41 +0800</pubDate></item><item><title>药物制剂元素杂质控制该如何做？</title><link>https://mp.weixin.qq.com/s/TvvXScs5hhgxv5yzXQvPtg</link><description></description><content:encoded><![CDATA[药物制剂元素杂质控制该如何做？]]></content:encoded><pubDate>Wed, 14 Apr 2021 20:26:51 +0800</pubDate></item></channel></rss>